# BRAIN Biotech

its BRAINBiocatalysts segment supplies enzymes, microorganisms and ingredients for industrial use alongside CRO activity and production-strain development, and it holds a granted European patent (EP4301852 B1) for the CRISPR-BMC nuclease. The nuclease is active across prokaryotic and eukaryotic organisms — bacteria,…

Source: https://en.bioecon.ru/companies/brain-biotech/
Updated: 2026-08-15

- Country: Germany

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | €49.6 million (FY 2024/25) | https://www.brain-biotech-group.com/en/investors/brain-biotech-ag-at-a-glance/, https://www.brain-biotech-group.com/en/news-media/press-releases/fy-202425-brain-biotech-ag/, https://www.brain-biotech.com/ecomaXL/files/2026-01-12_BRAIN_Biotech_GB_EN-FINAL.pdf, https://www.brain-biotech.com/ecomaXL/files/3M_Report_2025-26_EN_final_BRAIN_Biotech.pdf |
| Headcount | around 280 employees (as of September 2025) | https://www.brain-biotech-group.com/en/investors/brain-biotech-ag-at-a-glance/, https://www.brain-biotech-group.com/en/news-media/press-releases/fy-202425-brain-biotech-ag/, https://www.brain-biotech.com/ecomaXL/files/2026-01-12_BRAIN_Biotech_GB_EN-FINAL.pdf, https://www.brain-biotech.com/ecomaXL/files/3M_Report_2025-26_EN_final_BRAIN_Biotech.pdf |
| Production site | Zwingenberg (Germany), Potsdam (Germany), Cardiff (UK), Nieuwkuijk (Netherlands), Büttelborn (Germany), Tampa (USA) | https://www.brain-biotech.com/en/faq/ |
| Capacity | process scale-up to 10 m3 at Cardiff facility | https://www.brain-biotech.com/en/news-events/news/methanol-free-komagataella-phaffii-pichia-pastoris-system-for-scalable-cost-effective-industrial-protein-production/ |
| Certification | ISO 9001, ISO 14001, ISO 45001, FSSC 22000, Kosher, Halal, SEDEX membership (varies by site) | https://www.brain-biotech-group.com/ecomaXL/files/Sustainability_Report_VSME_FY_2023-24.pdf |
| Regulatory approval | Support for EFSA and FDA dossiers; compliance with food/pharma safety standards | https://www.brain-biotech.com/en/faq/ |
| Funding | Publicly funded projects (EU, BMBF, BMWK, FFG), research tax credits, and potential milestone payments (e.g., up to ~€92M from Akribion, ~€138M from Pharvaris/Royalty Pharma) | https://seat11a.com/company/brain-biotech-ag-company-presentation/, https://www.brain-biotech.com/ecomaXL/files/3M_Report_2025-26_EN_final_BRAIN_Biotech.pdf |

Independent sources: seat11a.com

## Technologies

- [Strain engineering (synbio CRO)](https://en.bioecon.ru/technology/strain-engineering-synbio-cro/)